PHARNEXT

pharnext-logo

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Ph... arnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

#SimilarOrganizations #People #Financial #Website #More

PHARNEXT

Social Links:

Industry:
Biopharma Biotechnology Medical Neuroscience Pharmaceutical

Founded:
2007-04-01

Address:
Issy-les-moulineaux, Ile-de-France, France

Country:
France

Website Url:
http://www.pharnext.com

Total Employee:
11+

Status:
Active

Contact:
33 1 55 42 62 00

Email Addresses:
[email protected]

Total Funding:
357.81 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS


Similar Organizations

ablynx-logo

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.

acacia-pharma-logo

Acacia Pharma

Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.

biontech-logo

BioNTech

BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

boaoxin-logo

Boaoxin

Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

dunad-therapeutics-logo

Dunad Therapeutics

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

enimmune-logo

Enimmune

Enimmune is a medical company engaged in the development of drugs through research and studies.

faron-pharmaceuticals-logo

Faron Pharmaceuticals

Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.

institute-of-biomedical-research-logo

Institute of BioMedical Research

InstituteBMR is a biotech company engaged in the research and manufacture of medical products such as microbicidal agents and disinfectants.

kiadis-pharma-logo

Kiadis Pharma

Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.

nmd-pharma-logo

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

oxford-cannabinoid-technologies-logo

Oxford Cannabinoid Technologies

OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

quercis-pharma-logo

Quercis Pharma

Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

urovant-sciences-logo

Urovant Sciences

Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.

ziphius-logo

Ziphius

Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.


Current Advisors List

michel-rosen_image

Michel Rosen Member of Board of Directors @ Pharnext
Board_member

Current Employees Featured

susanne-dorn_image

Susanne Dorn
Susanne Dorn Chief Regulatory Officer @ Pharnext
Chief Regulatory Officer

rodolphe-hajj_image

Rodolphe Hajj
Rodolphe Hajj Chief Pharmacology Officer @ Pharnext
Chief Pharmacology Officer

serge-fitoussi_image

Serge Fitoussi
Serge Fitoussi Chief Medical Officer @ Pharnext
Chief Medical Officer
2018-11-01

serguei-nabirotchkin_image

Serguei Nabirotchkin
Serguei Nabirotchkin Co-founder and Chief Biology Officer @ Pharnext
Co-founder and Chief Biology Officer
2006-01-01

daniel-cohen_image

Daniel Cohen
Daniel Cohen Co-founder, Chief Executive Officer @ Pharnext
Co-founder, Chief Executive Officer

philippe-pouletty_image

Philippe Pouletty
Philippe Pouletty Co-Founder @ Pharnext
Co-Founder

xavier-paoli_image

Xavier Paoli
Xavier Paoli VP, Chief Commercial Officer @ Pharnext
VP, Chief Commercial Officer
2017-01-01

peter-collum_image

Peter Collum
Peter Collum Chief Financial Officer and Chief Business Officer @ Pharnext
Chief Financial Officer and Chief Business Officer

Founder


daniel-cohen_image

Daniel Cohen

philippe-pouletty_image

Philippe Pouletty

serguei-nabirotchkin_image

Serguei Nabirotchkin

Stock Details


Company's stock symbol is EPA:ALPHA

Investors List

truffle-capital_image

Truffle Capital

Truffle Capital investment in Venture Round - Pharnext

parinvest_image

Parinvest

Parinvest investment in Venture Round - Pharnext

parinvest_image

Parinvest

Parinvest investment in Series B - Pharnext

truffle-capital_image

Truffle Capital

Truffle Capital investment in Series B - Pharnext

financière-boscary_image

Financière Boscary

Financière Boscary investment in Series A - Pharnext

truffle-capital_image

Truffle Capital

Truffle Capital investment in Series A - Pharnext

aurinvest_image

Aurinvest

Aurinvest investment in Series A - Pharnext

Official Site Inspections

http://www.pharnext.com Semrush global rank: 2.75 M Semrush visits lastest month: 5.88 K

  • Host name: vps-dfbc05b4.vps.ovh.net
  • IP address: 146.59.158.100
  • Location: Norway
  • Latitude: 59.9452
  • Longitude: 10.7559
  • Timezone: Europe/Oslo

Loading ...

More informations about "Pharnext" on Search Engine